Theis Terwey is the founder of GH Research. GH Research has raised $300M in total funding. Latest round: IPO. Based in Dublin, Ireland.
Theis Terwey is the founder and former Chief Executive Officer of GH Research, a clinical-stage biopharmaceutical company focused on psychedelic treatments for depression. He co-founded the company in 2018 and guided it through its June 2021 Nasdaq IPO and into Phase 2b clinical development, overseeing the raising of over $300 million before stepping down as CEO.
Full founder directory · Investor directory · Company funding database · Fundraising library